Reaction Details |
| Report a problem with these data |
Target | C-C chemokine receptor type 5 |
---|
Ligand | BDBM50441712 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_988290 (CHEMBL2439744) |
---|
IC50 | 1.7±n/a nM |
---|
Citation | Skerlj, R; Bridger, G; Zhou, Y; Bourque, E; McEachern, E; Metz, M; Harwig, C; Li, TS; Yang, W; Bogucki, D; Zhu, Y; Langille, J; Veale, D; Ba, T; Bey, M; Baird, I; Kaller, A; Krumpak, M; Leitch, D; Satori, M; Vocadlo, K; Guay, D; Nan, S; Yee, H; Crawford, J; Chen, G; Wilson, T; Carpenter, B; Gauthier, D; Macfarland, R; Mosi, R; Bodart, V; Wong, R; Fricker, S; Schols, D Design of substituted imidazolidinylpiperidinylbenzoic acids as chemokine receptor 5 antagonists: potent inhibitors of R5 HIV-1 replication. J Med Chem56:8049-65 (2013) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
C-C chemokine receptor type 5 |
---|
Name: | C-C chemokine receptor type 5 |
Synonyms: | C-C CKR-5 | C-C chemokine receptor type 5 | CC-CKR-5 | CCR-5 | CCR5 | CCR5/mu opioid receptor complex | CCR5_HUMAN | CD_antigen=CD195 | CHEMR13 | CMKBR5 | HIV-1 fusion coreceptor |
Type: | Enzyme |
Mol. Mass.: | 40540.21 |
Organism: | Homo sapiens (Human) |
Description: | P51681 |
Residue: | 352 |
Sequence: | MDYQVSSPIYDINYYTSEPCQKINVKQIAARLLPPLYSLVFIFGFVGNMLVILILINCKR
LKSMTDIYLLNLAISDLFFLLTVPFWAHYAAAQWDFGNTMCQLLTGLYFIGFFSGIFFII
LLTIDRYLAVVHAVFALKARTVTFGVVTSVITWVVAVFASLPGIIFTRSQKEGLHYTCSS
HFPYSQYQFWKNFQTLKIVILGLVLPLLVMVICYSGILKTLLRCRNEKKRHRAVRLIFTI
MIVYFLFWAPYNIVLLLNTFQEFFGLNNCSSSNRLDQAMQVTETLGMTHCCINPIIYAFV
GEKFRNYLLVFFQKHIAKRFCKCCSIFQQEAPERASSVYTRSTGEQEISVGL
|
|
|
BDBM50441712 |
---|
n/a |
---|
Name | BDBM50441712 |
Synonyms: | CHEMBL2435906 |
Type | Small organic molecule |
Emp. Form. | C30H40ClN5O2 |
Mol. Mass. | 538.124 |
SMILES | CC(CCNC(=O)c1c(C)cc(Cl)nc1C)N1CCC(CC1)N1[C@@H](CN(C2CCC2)C1=O)c1ccccc1 |r| |
Structure |
|